Related Experiment Video

Updated: Jan 5, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.3K

Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor

Chunhua Ma1, Chuoji Huang2,3, Dongjiang Tang2,3

  • 1Department of Intervention, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Disease, Tianjin, China.

Frontiers in Oncology
|October 24, 2019
PubMed

Insights

This study corrects a previous article DOI. It ensures accurate citation and access to the research findings for better scientific communication.

Area of Science:

  • Oncology
  • Biomedical Research

Background:

  • Ensuring the accuracy of scientific literature is crucial for reliable research.
  • Proper citation facilitates the retrieval and verification of published studies.

Purpose of the Study:

  • To correct a previously published article's Digital Object Identifier (DOI).
  • To ensure accurate referencing and accessibility of the research.

Main Methods:

  • A correction notice was issued for the article.
  • The correct DOI was provided for the specific publication.

Main Results:

  • The article DOI has been updated to 10.3389/fonc.2019.00628.
  • This correction rectifies a citation error in the scientific record.

Conclusions:

  • Accurate DOIs are essential for maintaining the integrity of scientific records.
  • This correction facilitates proper citation and access to the research.
Keywords:
G719A mutationNSCLCafatinibcerebrospinal fluidleptomeningeal metastases

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.2K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K